Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35-36
SponsorUniversity of Seville

About this trial

This study aims to investigate how moderate wine consumption influences circulating extracellular vesicles (EVs) in healthy adults. EVs are small particles released by cells that carry proteins, lipids, and genetic material, and play important roles in communication between cells. Participants will consume a single serving of red or white wine, and blood samples will be collected before and after consumption to study changes in the composition and function of EVs. The study will also assess how these EVs affect vascular, immune, and brain-related cells. The results are expected to improve our understanding of how moderate wine intake contributes to cardiovascular and brain health.

Eligibility criteria

Qualifiers

Healthy adult men and women aged 35 to 65 years.

Body Mass Index (BMI) between 18.5 and 29.9 kg/m².

Non-smokers or ex-smokers for at least 12 months.

Moderate alcohol consumers, defined as ≤2 units/day for men and ≤1 unit/day for women.

Disqualifiers

History or clinical evidence of cardiovascular, hepatic, renal, thyroid, gastrointestinal, or metabolic diseases (including diabetes, dyslipidemia, or hypertension).

Use of medications or supplements known to affect glucose, lipid, or inflammatory metabolism (e.g., statins, corticosteroids, anti-inflammatory drugs).

Pregnancy or breastfeeding.

Recent blood donation (within the last 3 months) or planned blood donation during the study period.

Trial design

Treatments tested in this trial

  • White Wine
  • Red Wine
  • Water

Treatment groups

8 Participants
are divided into 3 treatment groups

Sponsors and collaborators